Full name
"APTEKA 21" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.19.Z - Retail trade
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
52.10.B - Warehousing and storage of other goods
64.99.Z - Other financial services, except insurance and pension funds, not elsewhere classified
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | -0,2 | -0,3 | -0,4 | -72,5 |
Gross profit (loss) | -0,2 | -0,1 | -0,3 | -196,1 |
EBITDA | -0,2 | -0,3 | -0,5 | -70,6 |
Short time liabilities | 1,2 | 1,1 | 1,1 | 1,1 |
Other operating costs | 0 | 0 | 0 | 0,9 |
Equity capital | 2,1 | 2 | 1,7 | -15,6 |
Operating profit (EBIT) | -0,2 | -0,3 | -0,5 | -68,1 |
Assets | 3,3 | 3,1 | 2,8 | -9 |
Net profit (loss) | -0,2 | -0,1 | -0,3 | -189,7 |
Cash | 0 | 0 | 0 | -36,6 |
Net income from sale | 5,6 | 5,9 | 6,2 | 5,1 |
Liabilities and provisions for liabilities | 1,2 | 1,2 | 1,2 | 2,3 |
Working assets | 3,2 | 3,1 | 2,8 | -9,1 |
Other income costs | 0 | 0 | 0 | -66,5 |
Depreciation | 0 | 0 | 0 | -16,2 |
% | % | % | p.p. | |
Profitability of capital | -8,8 | -5,4 | -18,5 | -13,1 |
Equity capital to total assets | 62,6 | 62,8 | 58,2 | -4,6 |
Gross profit margin | -3,2 | -1,8 | -5,1 | -3,3 |
EBITDA Margin | -4,2 | -4,7 | -7,6 | -2,9 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 78 | 69 | 66 | -3 |
Current financial liquidity indicator | 2.6799917221069336 | 2.7652366161346436 | 2.4854414463043213 | -0,3 |
Net dept to EBITDA | 0.05010046064853668 | 0.05093299597501755 | 0.01891699992120266 | -0,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane